James Munday is the Director and Global Head of Immunology & Immunotoxicology at Labcorp, a role they have held since 2023. Prior to this, James served as Associate Director at Labcorp Drug Development, leading global and EU immunology efforts from 2022 to 2023. Their career includes positions as Senior Scientist at Quotient Bioresearch and UCB Pharma, as well as multiple leadership roles at Covance from 2014 to 2021. James also completed postdoctoral studies in Stem Cell Biology at the Icahn School of Medicine at Mount Sinai and earned a D.Phil in Molecular Cell Biology from the University of Oxford.
This person is not in the org chart
This person is not in any teams
This person is not in any offices